1. 853PARCHES - The role of androgen deprivation therapy (ADT) with enzalutamide (ENZA) or placebo (PBO) in metastatic hormone-sensitive prostate cancer (mHSPC): Post hoc analyses of high and low disease volume and risk groups. (1st October 2019) Authors: Stenzl, A; Szmulewitz, R Z; Petrylak, D P; Holzbeierlein, J; Villers, A; Azad, A A; Alcaraz, A; Alekseev, B Y; Iguchi, T; Shore, N D; Rosbrook, B; Baron, B; Haas, G P; Morlock, R; Ramaswamy, K; Armstrong, A J Journal: Annals of oncology Issue: Volume 30(2019)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗